Kim-Mitsuyama, Shokei
,
Ogawa, Hisao
Matsui, Kunihiko
Jinnouchi, Tomio
Jinnouchi, Hideaki
Arakawa, Kikuo
Article History
Received: 17 July 2014
Revised: 26 September 2014
Accepted: 23 October 2014
First Online: 4 December 2014
Competing interests
: Shokei Kim-Mitsuyama has received consultancy or lecture fees/honoraria from AstraZeneca, Astellas, Boerhinger Ingelheim, Daiichi-Sankyo, Kyowa Hakko Kirin, Novartis, Takeda and Shionogi, and received research grants from AstraZeneca, Astellas, Boerhinger Ingelheim, Daiichi-Sankyo, Kyowa Hakko Kirin, Novartis, Takeda, Shionogi and Mochida. Hisao Ogawa has received research grant from the Japan Heart Foundation for this study, has received consultancy or lecture fees/honoraria from Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Daiichi-Sankyo, Eisai, Kowa, Kyowa Hakko Kirin, MSD, Novartis, Pfizer, Sanofi-Aventis, Schering-Plough and Takeda, and has received research grants from Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Daiichi-Sankyo, Kowa, MSD, Novartis, Pfizer, Sanofi-Aventis, Otsuka, Chugai, Bristol-Myers Squibb, Dainippon Sumitomo and Takeda. All other authors declare no conflict of interest.